Joshua Boger


Founder, Vertex Pharmaceuticals 

Dr. Boger joined Alkeus Pharma as Executive Chairman in May 2012, three years after he retired as Chief Executive Officer of Vertex Pharmaceuticals. As founder of Vertex, he led the company’s efforts to develop science-based transformative medicines for over 20 years, transforming the firm into a successful global enterprise counting over 2,000 employees today. Vertex’s gripping story was profiled in two books: The Billion-Dollar Molecule (1995) and The Antidote (2014). Dr. Boger was also a pioneer in setting up alliances between Pharma and disease-focused foundations, which resulted in the commercialization of the first drug to address the genetic defect associated with Cystic Fibrosis.

Dr. Boger continues to serve on the board of Vertex. He is also the Chair of the Board of Harvard Medical School, Chair of the Board of Trustees at Wesleyan University, Chair of NEHI (the Network for Healthcare Innovation), board member of the Biotechnology Industry Organization (BIO), of the Whitehead Institute for Biomedical Research, the Hastings Center and the Massachusetts Life Sciences Center. He is also the Chair of the Board of the Celebrity Series (Boston), Vice-Chair of the Alliance for Business Leadership, Vice-Chair of the Museum of Science (Boston), and serves on additional boards such as the Harvard Board of Overseers, the American Civil Liberties Union of Massachusetts Foundation, the Science Advisory Council of WGBH, the Massachusetts Workforce Investment Board and MassChallenge.

Dr. Boger began his industry career at Merck and holds a Ph.D. degree in chemistry from Harvard University and a BA in chemistry and philosophy from Wesleyan University.